Search results for:
eculizumab
eculizumab
| Drug Name |
Form |
Strength |
ARHS |
Blue Ridge |
Caldwell |
Chatham |
Johnston |
Lenoir |
Medical Center |
Nash |
Pardee |
Rex |
Rockingham |
Southeastern |
Wayne |
Youth Behavioral Health |
| Eculizumab |
SOLUTION, INTRAVENOUS |
10 mg/mL (30 mL) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Eculizumab-aagh |
SOLUTION, INTRAVENOUS |
10 mg/mL (30 mL) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Last updated: Jul. 1, 2025
Add Formweb to your mobile device
UNC Health
System Formulary Restriction:
Use of eculizumab (Soliris) injection is restricted to outpatient encounters or clinic use only (ie, no inpatient use)
UNC Health IV Compendium Guideline
Med Center
UNC Medical Center Formulary Restrictions
Eculizumab (Soliris) Dispensing Form
Rex
Rex Hematology-Oncology Formulary Restrictions